OR WAIT null SECS
© 2021 MJH Life Sciences and Contemporary OB/GYN. All rights reserved.
© 2021 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
Results of the HERS, ERA, and WHI trials suggest a conservative approach to use of HRT in women with evidence of CHD. Dose and duration of therapy may be key to the risk-benefit equation.